home / stock / acad / acad articles
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) shares are trading higher Wednesday after the company won summary judgement in a patent suit regard...
NEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigati...
JP Morgan increased ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) price target from $29 to $32. JP Morgan analyst Tessa Romero upgraded the stock f...
Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing...
News, Short Squeeze, Breakout and More Instantly...
ACADIA Pharmaceuticals Inc. Company Name:
ACAD Stock Symbol:
NASDAQ Market:
ACADIA Pharmaceuticals Inc. Website:
2024-06-26 17:30:03 ET BMO Capital analyst issues OUTPERFORM recommendation for ACAD on June 26, 2024 04:09PM ET. The previous analyst recommendation was Buy. ACAD was trading at $15.5 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curre...
2024-06-26 17:00:07 ET Keith Tapper from BMO Capital issued a price target of $31.00 for ACAD on 2024-06-26 16:09:00. The adjusted price target was set to $31.00. At the time of the announcement, ACAD was trading at $15.5. The overall price target consensus is at $26.25 ...
2024-06-19 14:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...